SCHEMBL8700410

SCHEMBL8700410

Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C(=O)O)C(C)C)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ NLRP3 Q96P20 3/20 0.46
▸ HPGD P15428 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ MAPT P10636 2/20 0.45
▸ POLB P06746 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ GAA P10253 2/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ USP2 O75604 1/20 0.42
▸ NLRP1 Q9C000 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6357275 0.89 EPHX2 (0.48) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL19602224 0.86 ALDH1A1 (0.49) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL6357782 0.85 NLRP3 (0.52) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL6355171 0.84 SMN1; SMN2 (0.52) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL6355594 0.82 PPARG (0.50) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL8409841 0.81 SMN1; SMN2 (0.48) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL6357278 0.81 EPHX2 (0.52) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL6359228 0.80 PPARG (0.47) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL12998282 0.78 MEN1 (0.53) ALDH1A1KMT2AMEN1L3MBTL1NLRP3
SCHEMBL6485462 0.78 LMNA (0.42) ALDH1A1KMT2AMEN1L3MBTL1NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5731454-A Allosteric modifiers of hemoglobin useful for decreasing oxygen affinity and preserving oxygen carrying capability of stored blood VIRGINIA COMMONWEALTH UNIVERSITY (US) 1998-03-24 — — US disclosed
US-5705521-A Use of allosteric hemoglobin modifiers in combination with radiation therapy to treat carcinogenic tumors THE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1998-01-06 — — US disclosed
US-5591892-A CARBOXYALKOXYPHENYL SUBSTITUTED INDANES CENTER FOR INNOVATIVE TECHNOLOGY (US) 1997-01-07 — — US disclosed
US-5432191-A Ring-substituted phenoxymethyl /or substituted methyl/ carboxylates THE CENTER FOR INNOVATIVE TECHNOLOGY (US) 1995-07-11 — — US disclosed
Send feedback